Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Identification of Potent and Selective Inhibitors of Acanthamoeba: Structural Insights into Sterol 14α-Demethylase as a Key Drug Target

Journal Article · · Journal of Medicinal Chemistry
 [1];  [2];  [3];  [2];  [2];  [1];  [1]
  1. Vanderbilt Univ., Nashville, TN (United States). School of Medicine
  2. Swansea University (United Kingdom)
  3. Northwestern Univ., Argonne, IL (United States). Synchrotron Research Center

Acanthamoeba are free-living pathogenic protozoa that cause blinding keratitis, disseminated infection, and granulomatous amebic encephalitis, which is generally fatal. The development of efficient and safe drugs is a critical unmet need. Acanthamoeba sterol 14α-demethylase (CYP51) is an essential enzyme of the sterol biosynthetic pathway. Repurposing antifungal azoles for amoebic infections has been reported, but their inhibitory effects on Acanthamoeba CYP51 enzymatic activity have not been studied. Here, we report catalytic properties, inhibition, and structural characterization of CYP51 from Acanthamoeba castellanii. The enzyme displays a 100-fold substrate preference for obtusifoliol over lanosterol, supporting the plant-like cycloartenol-based pathway in the pathogen. The strongest inhibition was observed with voriconazole (1 h IC50 0.45 μM), VT1598 (0.25 μM), and VT1161 (0.20 μM). The crystal structures of A. castellanii CYP51 with bound VT1161 (2.24 Å) and without an inhibitor (1.95 Å), presented here, can be used in the development of azole-based scaffolds to achieve optimal amoebicidal effectiveness.

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
USDOE Office of Science (SC), Basic Energy Sciences (BES)
Grant/Contract Number:
AC02-06CH11357
OSTI ID:
2470115
Journal Information:
Journal of Medicinal Chemistry, Journal Name: Journal of Medicinal Chemistry Journal Issue: 9 Vol. 67; ISSN 0022-2623
Publisher:
American Chemical Society (ACS)Copyright Statement
Country of Publication:
United States
Language:
English

References (76)

Role of the Alanine at Position 363 of Cytochrome P450 2B2 in Influencing the NADPH- and Hydroperoxide-Supported Activities journal February 1998
In vitro comparative assessment of different viability assays in Acanthamoeba castellanii and Acanthamoeba polyphaga trophozoites journal September 2013
Cloning and characterization of the Dictyostelium discoideum cycloartenol synthase cDNA journal March 2000
Oteseconazole: First Approval journal June 2022
Acanthamoeba keratitis with live isolates treated with cryosurgery and fluconazole journal June 1999
The Carbon Monoxide-binding Pigment of Liver Microsomes journal July 1964
Anti-amoebic potential of azole scaffolds and nanoparticles against pathogenic Acanthamoeba journal November 2020
Sterol 14α-demethylase cytochrome P450 (CYP51), a P450 in all biological kingdoms journal March 2007
Ligand tunnels in T. brucei and human CYP51: Insights for parasite-specific drug design journal January 2016
Sterol 14α-Demethylase as a Potential Target for Antitrypanosomal Therapy: Enzyme Inhibition and Parasite Cell Growth journal November 2007
Acanthamoeba and its pathogenic role in granulomatous amebic encephalitis journal January 2020
A simple method for the determination of reduction potentials in heme proteins journal January 2014
Sequence variation in CYP51A from the Y strain of Trypanosoma cruzi alters its sensitivity to inhibition journal September 2014
Isavuconazole and voriconazole inhibition of sterol 14α-demethylases (CYP51) from Aspergillus fumigatus and Homo sapiens journal October 2019
CYP51 structures and structure-based development of novel, pathogen-specific inhibitory scaffolds journal December 2012
Processive kinetics in the three-step lanosterol 14α-demethylation reaction catalyzed by human cytochrome P450 51A1 journal July 2023
Acanthamoeba spp. as a universal host for pathogenic microorganisms: One bridge from environment to host virulence journal December 2016
A convergent, scalable and stereoselective synthesis of azole CYP51 inhibitors journal November 2017
Microtitre plate-based antibacterial assay incorporating resazurin as an indicator of cell growth, and its application in the in vitro antibacterial screening of phytochemicals journal August 2007
CYP51 as drug targets for fungi and protozoan parasites: past, present and future journal April 2018
Relaxed Substrate Requirements of Sterol 14α-Demethylase from Naegleria fowleri Are Accompanied by Resistance to Inhibition journal November 2021
Sterol 14α-Demethylase Structure-Based Design of VNI (( R )- N -(1-(2,4-Dichlorophenyl)-2-(1 H -imidazol-1-yl)ethyl)-4-(5-phenyl-1,3,4-oxadiazol-2-yl)benzamide)) Derivatives To Target Fungal Infections: Synthesis, Biological Evaluation, and Crystallographic Analysis journal June 2018
Sterol 14α-Demethylase Structure-Based Optimization of Drug Candidates for Human Infections with the Protozoan Trypanosomatidae journal November 2018
Validation of Human Sterol 14α-Demethylase (CYP51) Druggability: Structure-Guided Design, Synthesis, and Evaluation of Stoichiometric, Functionally Irreversible Inhibitors journal October 2019
CYP51 from Trypanosoma brucei Is Obtusifoliol-Specific journal August 2004
Structural Basis for Rational Design of Inhibitors Targeting Trypanosoma cruzi Sterol 14α-Demethylase: Two Regions of the Enzyme Molecule Potentiate Its Inhibition journal July 2014
A randomized masked pilot clinical trial to compare the efficacy of topical 1% voriconazole ophthalmic solution as monotherapy with combination therapy of topical 0.02% polyhexamethylene biguanide and 0.02% chlorhexidine in the treatment of Acanthamoeba keratitis journal July 2020
Characterisation of sterol biosynthesis and validation of 14α-demethylase as a drug target in Acanthamoeba journal August 2017
Unravelling the role of transient redox partner complexes in P450 electron transfer mechanics journal September 2022
Sterol biosynthesis de nova via cycloartenol by the soil amoeba Acanthamoeba polyphaga journal November 1985
An update onAcanthamoebakeratitis: diagnosis, pathogenesis and treatment journal January 2015
Sterol phylogenesis and algal evolution. journal October 1990
Crystal Structures of Trypanosoma brucei Sterol 14α-Demethylase and Implications for Selective Treatment of Human Infections journal November 2009
Structural Insights into Inhibition of Sterol 14α-Demethylase in the Human Pathogen Trypanosoma cruzi journal June 2010
Complexes of Trypanosoma cruzi Sterol 14α-Demethylase (CYP51) with Two Pyridine-based Drug Candidates for Chagas Disease : STRUCTURAL BASIS FOR PATHOGEN SELECTIVITY journal September 2013
Structure-Functional Characterization of Cytochrome P450 Sterol 14α-Demethylase (CYP51B) from Aspergillus fumigatus and Molecular Basis for the Development of Antifungal Drugs journal August 2015
Structural analyses of Candida albicans sterol 14α-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis journal March 2017
Binding of a physiological substrate causes large-scale conformational reorganization in cytochrome P450 51 journal October 2018
VNI Cures Acute and Chronic Experimental Chagas Disease journal January 2013
VFV as a New Effective CYP51 Structure-Derived Drug Candidate for Chagas Disease and Visceral Leishmaniasis journal April 2015
Concerning P450 Evolution: Structural Analyses Support Bacterial Origin of Sterol 14α-Demethylases journal October 2020
Paralog Re-Emergence: A Novel, Historically Contingent Mechanism in the Evolution of Antimicrobial Resistance journal April 2014
Fatal Granulomatous Amoebic Encephalitis Caused by Acanthamoeba in a Patient With Kidney Transplant: A Case Report journal July 2015
Microsomal P450s Use Specific Proline--Rich Sequences for Efficient Folding, but Not for Maintenance of the Folded Structure journal February 2001
Successful Treatment of Chronic Stromal Acanthamoeba Keratitis With Oral Voriconazole Monotherapy journal September 2010
Granulomatous amoebic encephalitis: ghost response of an immunocompromised host? journal December 2014
Features and development of Coot journal March 2010
Overview of the CCP 4 suite and current developments journal March 2011
Data processing and analysis with the autoPROC toolbox journal March 2011
How good are my data and what is the resolution? journal June 2013
Unravelling the interactions of the environmental hostAcanthamoeba castellaniiwith fungi through the recognition by mannose‐binding proteins journal June 2019
The action of the systemic fungicides tridemorph and fenpropimorph on sterol biosynthesis by the soil amoeba Acanthamoeba polyphaga journal April 1987
Bacterial Endosymbionts of Free‐living Amoebae1 journal September 2004
Characterization of the sterol 14α-demethylases of Fusarium graminearum identifies a novel genus-specific CYP51 function journal February 2013
Pandoraviruses: Amoeba Viruses with Genomes Up to 2.5 Mb Reaching That of Parasitic Eukaryotes journal July 2013
Azole Antifungal Agents To Treat the Human Pathogens Acanthamoeba castellanii and Acanthamoeba polyphaga through Inhibition of Sterol 14α-Demethylase (CYP51) journal August 2015
Minimal Cerebrospinal Fluid Concentration of Miltefosine despite Therapeutic Plasma Levels during the Treatment of Amebic Encephalitis journal December 2019
The Clinical Candidate VT-1161 Is a Highly Potent Inhibitor of Candida albicans CYP51 but Fails To Bind the Human Enzyme journal September 2014
Acanthamoeba spp. as Agents of Disease in Humans journal April 2003
Identification of Two Different 14-α Sterol Demethylase-Related Genes ( cyp51A and cyp51B ) in Aspergillus fumigatus and Other Aspergillus species journal July 2001
Crystal Structure of the New Investigational Drug Candidate VT-1598 in Complex with Aspergillus fumigatus Sterol 14α-Demethylase Provides Insights into Its Broad-Spectrum Antifungal Activity journal May 2017
Impact of the Major Candida glabrata Triazole Resistance Determinants on the Activity of the Novel Investigational Tetrazoles VT-1598 and VT-1161 journal October 2019
Clinical Candidate VT-1161's Antiparasitic Effect In Vitro , Activity in a Murine Model of Chagas Disease, and Structural Characterization in Complex with the Target Enzyme CYP51 from Trypanosoma cruzi journal December 2015
Biology and pathogenesis of Acanthamoeba journal January 2012
Human sterol 14α-demethylase as a target for anticancer chemotherapy: towards structure-aided drug design journal June 2016
Sterol methyltransferase a target for anti-amoeba therapy: towards transition state analog and suicide substrate drug design journal December 2017
Novel antifungal agents in clinical trials journal June 2021
Successful Treatment of DisseminatedAcanthamoebasp. Infection with Miltefosine journal November 2008
Hijacking Chemical Reactions of P450 Enzymes for Altered Chemical Reactions and Asymmetric Synthesis journal December 2022
A Systematic Review of Intracellular Microorganisms within Acanthamoeba to Understand Potential Impact for Infection journal February 2021
Environmental (Saprozoic) Pathogens of Engineered Water Systems: Understanding Their Ecology for Risk Assessment and Management journal June 2015
Gold Nanoparticles Conjugation Enhances Antiacanthamoebic Properties of Nystatin, Fluconazole and Amphotericin B journal January 2019
Treatment of Granulomatous Amoebic Encephalitis with Voriconazole and Miltefosine in an Immunocompetent Soldier journal October 2012
Acanthamoeba Infection in a Drowning Child journal May 2016
Amoebicidal effect of Fluconazole and Verapamil together against trophozoites and cysts of Acanthamoeba castellanii journal June 2023
Acanthamoeba Keratitis: A Single-Institution Series of Four Cases With Literature Review journal January 2022